Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party
Klaus Hirschbühl, Myriam Labopin, Mohamed Houhou, Ludovic Gabellier, Hélène Labussière-Wallet, Bruno Lioure, Dietrich Beelen, Jan Cornelissen, Gerald Wulf, Pavel Jindra, Hervé Tilly, Jakob Passweg, Riita Niittyvuopio, Gesine Bug, Christoph Schmid*, Arnon Nagler, Sebastian Giebel, Mohamad Mohty
Research output: Contribution to journal › Article › Academic › peer-review
12Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party'. Together they form a unique fingerprint.